Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)

NCT00424528 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

235

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease
Bronchitis
Emphysema

Interventions

DRUG: Arformoterol Tartrate Inhalation Solution
DRUG: Tiotropium
DRUG: Arformoterol and Tiotropium
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.